Neural development and neurodegeneration: Two faces of Neuropathy Target Esterase

Progress in Neurobiology

Volumn 61, Issue 1, 2000, Pages 61-74

  Glynn, Paul ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Active site; Axon; Gain of function; Organophosphate; Protein family

Indexed keywords

CALCIUM; CALPAIN; NEUROTOXIC ESTERASE; ORGANOPHOSPHATE; SERINE DEHYDRATASE; SERINE PROTEINASE; VALERIC ACID DERIVATIVE;

CATALYSIS; ENZYME ACTIVE SITE; GLIA CELL; HISTOPATHOLOGY; HUMAN; HYDROLYSIS; IN VITRO STUDY; NERVE DEGENERATION; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN SECONDARY STRUCTURE; REVIEW;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; HUMANS; NERVE DEGENERATION; NERVOUS SYSTEM; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0033964076     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00043-X     Document Type: Review

References (78)

1. Abou-Donia M.B., Lapadula D.M. Mechanisms of organophosphorus ester induced delayed neurotoxicity: Type I and Type II. Ann. Rev. Pharmacol. Toxicol. 30:1990;405-440.
2. Aldridge W.N., Reiner E. Enzyme Inhibitors as Substrates. 1972;Elsevier/North Holland, Amsterdam.
3. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate poisoning. Part I: Studies on myelin and axonal alterations in the sciatic nerve. Acta Neuropath. 9:1967;158-174.
4. Bischoff A. The ultrastructure of tri-ortho-cresyl phosphate poisoning. Part II: Studies on spinal cord alterations. Acta Neuropath. 15:1970;142-155.
5. Bouldin T.W., Cavanagh J.B. Organophosphorus neuropathy. Part I: A teased fibre study of the spatio-temporal spread of axonal degeneration. Am. J. Pathol. 94:1979;241-252.
6. Bouldin T.W., Cavanagh J.B. Organophosphorus neuropathy. Part II: A fine-structural study of the early stages of axonal degeneration. Am. J. Pathol. 94:1979;253-270.
7. Carrington C.D. Prophylaxis and the mechanism for the initiation of organophosphorus compound-induced delayed neurotoxicity. Arch. Toxicol. 63:1989;165-172.
8. Carrington C.D., Abou-Donia M.B. Axoplasmic transport and turnaround of neurotoxic esterase in hen sciatic nerve. J. Neurochem. 44:1985;616-621.
9. Casareno R.L.B., Waggoner D., Gitlin J.D. The copper chaperone CCS directly interacts with copper/zinc superoxide dismutase. J. Biol. Chem. 273:1998;23625-23628.
10. Casida J.E., Eto M., Baron R.L. Biological activity of a tri-o-cresyl phosphate metabolite. Nature. 191:1961;1396-1397.
11. Cavanagh J.B. The toxic effects of tri-ortho-cresyl phosphate on the nervous system: an experimental study in hens. J. Neurol. Neurosurg. Psychiat. 17:1954;163-172.
12. Cavanagh J.B. Peripheral nerve changes in tri-ortho-cresyl phosphate poisoning in the cat. J. Pathol. Bacteriol. 87:1964;365-383.
13. Cavanagh J.B., Patangia G.N. Changes in the central nervous system in the cat as a result of tri-o-cresyl phosphate poisoning. Brain. 88:1965;165-180.
14. Clothier B., Johnson M.K. Rapid aging of neurotoxic esterase after inhibition by di-isopropyl phosphorofluoridate. Biochem. J. 177:1979;549-558.
15. 2+, calcineurin and NF-AT. Cell. 96:1999;611-614.
16. Dodson G., Wlodawer A. Catalytic triads and their relatives. Trends in Biochem. Sci. 23:1998;347-352.
17. El-Fawal H.A.N., Jortner B.S., Ehrich M. Effect of verapamil on organophosphorus-induced delayed neuropathy in hens. Toxicol. Appl. Pharmacol. 97:1989;500-511.
18. El-Fawal H.A.N., Jortner B.S., Ehrich M. Use of the biventer cevicis nerve muscle preparation to detect early changes following exposure to organophosphates inducing delayed neuropathy. Fundament. Appl. Toxicol. 15:1990;108-120.
19. El-Fawal H.A.N., Correll L., Gay L., Ehrich M. Protease activity in brain, nerve and muscle of hens given neuropathy-inducing organophosphates and a calcium-channel blocker. Toxicol. Appl. Pharmacol. 103:1990;133-142.
20. Flaskos J., McLean W.G., Fowler M.J., Hargreaves A.J. Tricresyl phospahte inhibits the formation of axon-like processes and disrupts neurofilaments in cultures mouse N2a and rat PC12 cells. Neurosci. Letts. 242:1998;101-104.
21. George E.B., Glass J.D., Griffin J.W. Axotomy-induced axonal degeneration is mediated by calcium influx through ion-specific channels. J. Neuroscience. 15:1995;6445-6452.
22. Glass J.D., Brushart T.M., George E.B., Griffin J.W. Prolonged survival of transected nerve fibres in C57BL/Ola mice is an intrinsic characteristic of the axon. J. Neurocytol. 22:1993;311-321.
23. Glynn P., Holton J.L., Nolan C.C., Read D.J., Brown L., Hubbard A., Cavanagh J.B. Neuropathy target esterase: immunolocalisation to neuronal cell bodies and axons. Neuroscience. 83:1998;295-302.
24. Griffin J.W., George E.B., Chaudhry V. Wallerian degeneration in peripheral nerve disease. Balliere's Clinical Neurology. 5:1996;65-75.
25. Harp P., Tanaka D. Jr, Pope C.N. Potentiation of organophosphorus-induced delayed neurotoxicity folowing phenyl saligenin phosphate exposures in 2-, 5- and 8-week old chickens. Fundament. Appl. Toxicol. 37:1997;64-70.
26. Henschler D., Schmuck G., van Aerssen M., Schiffmann D. The inhibitory effect of neuropathic organophosphate esters on neurite outgrowth in cell cultures: a basis for screening for delayed neurotoxicity. Toxic. In vitro. 6:1992;327-335.
27. Herbert C.B., Bittner G.D., Hubbell J.A. Effets of fibrinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J. Comp. Neurol. 365:1996;380-391.
28. Hofmann K., Stoffel W. TMbase - A database of membrane spanning protein segments. Biol. Chem. Hoppe Seyler. 34:1993;166.
29. Johnson M.K. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. Biochem. J. 111:1969;487-495.
30. Johnson M.K. The delayed neurotoxic effect of some organophosphorus compounds: identification of the phosphorylation site as an esterase. Biochem. J. 114:1969;711-714.
31. Johnson M.K. The primary biochemical lesion leading to the delayed neurotoxic effects of some organophosphorus esters. J. Neurochem. 23:1974;785-789.
32. Johnson M.K. Structure-activity relationships for substrates and inhibitors of hen brain neurotoxic esterase. Biochem. Pharmacol. 24:1975;797-805.
33. Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicty potential. Arch. Toxicol. 37:1977;113-115.
34. Johnson M.K. The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Hodgson E., Bend J.R., Philpot R.M. Reviews in Biochemical Toxicology. vol. 4:1982;141-212 Elsevier, New York.
35. Johnson M.K. Sensitivity and selectivity of compounds interacting with neuropathy target esterase: further structure/activity studies. Biochem. Pharmacol. 37:1988;4095-4104.
36. Johnson M.K. Organophosphates and delayed neuropathy - is NTE alive and well? Toxicol. Appl. Pharmacol. 102:1990;385-399.
37. Johnson M.K., Barnes J.M. Age and the sensitivity of chicks to the delayed neurotoxic effects of some organophosphorus compounds. Biochem. Pharmacol. 19:1970;3045-3047.
38. Johnson M.K., Read D.J. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and prophylactic effects of stereoisomers of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo. Toxicol. Appl. Pharmacol. 90:1987;103-115.
39. Jortner B.S., Ehrich M. Neuropathological effects of phenyl saligenin phospahte in chickens. Neurotoxicology. 8:1987;97-108.
40. Jortner B.S., Shell L., El-Fawal H., Ehrich M. Myelinated nerve fiber regeneration following organophosphorus ester-induced delayed neuropathy. Neurotoxicology. 10:1989;717-726.
41. Kanoh H., Kai M., Wada I. Phosphatidic acid phosphatase from mammalian tissues: discovery of channel-like proteins with unexpected functions. Biochim. Biophys. Acta. 1348:1997;56-62.
42. Krejci E., Duval N., Chatonnet A., Vincens P., Massoulie J. Cholinesterase-like domains in enzymes and structural proteins: functional and evolutionary relationships and identification of a catalytically essential aspartic acid. Proc. Nat. Acad. Sci. USA. 88:1991;6647-6651.
43. Kretzschmar D., Hasan G., Sharma S., Heisenberg M., Benzer S. The swiss cheese mutant causes glial hyperwrapping of and brain degeneration in Drosophila. J. Neuroscience. 17:1997;7425-7432.
44. Le Vay S., Meier C., Glees P. Effects of tri-ortho-cresyl phosphate on spinal ganglia and peripheral nerves of chicken. Acta Neuropath. 17:1971;103-113.
45. Li W., Casida J.E. Organophosphorus neuropathy target esterase. Inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells. Toxicol. Letts. 98:1998;139-146.
46. Liu J., Farmer J.D. Jr, Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin- cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
47. Lotti M. The pathogenesis of organophosphate polyneuropathy. Crit. Rev. Toxicol. 21:1992;465-487.
48. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Europ. J. Neuroscience. 1:1989;27-33.
49. Lush M.J., Li Y., Read D.J., Willis A.C., Glynn P. Neuropathy target esterase and a homologous Drosophila neurodegeneration mutant protein contain a domain conserved from bacteria to man. Biochem. J. 332:1998;1-4.
50. Medda S., Stevens A.M., Swank R.T. Involvement of the esterase active site of egasyn in the compartmentalisation of beta-glucuronidase within the endoplasmic reticulum. Cell. 50:1987;301-310.
51. Meredith C., Johnson M.K. Neuropathy target esterase: rates of turnover in vivo following covalent inhibition with phenyl di-n-pentylphosphinate. J. Neurochem. 51:1988;1097-1101.
52. Moser, M., Stempl, T., Li, Y., Glynn, P., Buttner, R., Kretzschmar, D., 1999. Molecular cloning of the mouse NTE/SWS gene. Mech. Dev. (in press).
53. Moretto A., Bertolazzi M., Lotti M. The phosphorothioic acid O-(2-chloro-2,3,3-trifluororcyclobutyl) O-ethyl S-propyl ester exacerbates organophosphorus polyneuropathy without inhibition of neuropathy target esterase. Toxicol. Appl. Pharmacol. 129:1994;133-137.
54. Moretto A., Capodicasa E., Peraica M., Lotti M. Age sensitivity to organophosphate-induced deleyed neuropathy: biochemical and toxicological studies in developing chicks. Biochem. Pharmacol. 41:1991;1497-1504.
55. Moretto A., Lotti M., Sabri M.I., Spencer P.S. Progressive deficit of retrograde axonal transport is associated with pathogenesis of di-n-dibutyl dichlorvos axonopathy. J. Neurochem. 49:1987;1515-1522.
56. Nystuen A., Benke P.J., Merren J., Stone E., Sheffield V.C. A cerebellar ataxia locus identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands. Human Mol. Genet. 5:1996;525-531.
57. Ollis D.L., Cheah E., Cygler M., Dijkstra B., Frolow F., Franken S.M., Harel M., Remington S.J., Silman I., Schrag J., Sussman J.L., Verschueren K.H.G., Goldman A. The alpha/beta hydrolase fold. Protein Engineering. 5:1992;197-211.
58. Ordentlich A., Barak D., Kronman C., Benschop H.P., de Jong L.P.A., Ariel N., Barak R., Segall Y., Velan B., Shafferman A. Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers. Biochemistry. 38:1999;3055-3066.
59. Perry V.H., Brown M.C., Lunn E.R., Tree P., Gordon S. Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Europ. J. Neuroscience. 2:1990;802-808.
60. Pope C.N., Padilla S.S. Chromatographic characterisation of neurotoxic esterase. Biochem. Pharmacol. 38:1989;181-188.
61. Pittman R.N., DiBenedetto A.J. PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate faster than control cells in complex extracellular matrix. J. Neurochem. 64:1995;566-575.
62. Prineas J. The pathogenesis of the dying-back neuropathies. Part I: An ultrastructural study of tri-ortho-cresyl phosphate intoxication in the cat. J. Neuropath. Exp. Neurol. 28:1969;571-597.
63. Ribchester R.R., Tsao J.W., Barry J.A., Asgari-Jirhandeh N., Perry V.H., Brown M.C. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/Wld(S)). Europ. J. Neuroscience. 7:1995;1641-1650.
64. Richards P., Johnson M.K., Ray D., Walker C. Novel protein targets for organophosphorus compounds. Chem. Biol. Interact. 119/120:1999;503-511.
65. Richardson R.J., Davis C.S., Johnson M.K. Subcellular distribution of marker enzymes and of neurotoxic esterase in adult hen brain. J. Neurochem. 32:1979;607-615.
66. Robertson D.G., Mattson A.M., Bestervelt L.L., Richardson R.J., Anderson R.J. Time course of electrophysiological effects induced by di-n- butyl-2,2-dichlorovinyl phosphate in the adult hen. J. Toxicol. Environ. Health. 23:1988;283-294.
67. Romanic A.M., Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4:1994;145-156.
68. Ross C.A., Margolis R.L., Becher M.W., Wood J.D., Engelender S., Cooper J.K., Sharp A.H. Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions. Progrss in Brain Res. 117:1998;397-419.
69. Smith, M.I., Elove, E. and Frazier, W.H., 1930. The pharmacological action of certain phenol esters with special reference to the etiology of the so-called Ginger paralysis. Public Health Reports, vol. 45, 2509-2524.
70. Sussman J.L., Harel M., Frolow F., Oefner C., Goldman A., Toker L., Silman I. Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science. 253:1991;872-879.
71. Taylor P. Impact of recombinant DNA technology and protein structure determination on past and future studies on acetylcholinesterase. Shafferman A., Velan B. Multidisciplinary Approaches to Cholinesterase Functions. 1992;1-15 Plenum Press, New York.
72. Thomas T.C., Szekacs A., Rojas S., Hammock B.D., Wilson B.W., MacNamee M.G. Characterisation of neuropathy target esterase using trifluoromethyl ketones. Biochem. Pharmacol. 40:1990;2587-2596.
73. Turgeon V.L., Houenou L.J. The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res.- Brain Res. Reviews. 25:1997;85-95.
74. Vance J.E. Eukaryotic lipid-biosynthetic enzymes: the same but not the same. Trends in Biochem. Sci. 23:1998;423-428.
75. Vigny M., Bon S., Massoulie J., Leterrier F. Active-site catalytic efficiency of acetylcholinesterase molecyular forms in Electrophorus, torpedo, rat and chicken. Europ. J. Biochem. 85:1978;317-323.
76. Williams C.H. Beta-glucuronidase activity in the serum and liver of rats administered pesticides and hepatotoxic agents. Toxicol. Appl. Pharmacol. 14:1969;283-292.
77. Williams D.G., Johnson M.K. Gel electrophoretic identification of hen brain neurotoxic esterase labelled with tritiated di-isopropyl phosphorofluoridate. Biochem. J. 199:1981;323-333.
78. Wu S.-Y., Casida J.E. Neuropathy target esterase inhibitors: 2- alkyl-, 2-alkoxy-, and 2-(aryloxy)-4H-1,3,2-benzodioxaphosphorin 2-oxides. Chem. Res. Toxicol. 5:1992;680-684.